Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy

Concurrent chemoradiotherapy with high-dose cisplatin (100 mg/m2 every 3 weeks) is the preferred regimen with curative intent for patients with unresected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). This treatment is associated with acute and late toxicities, including...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Frontiers in Oncology
Main Authors:	Sandro V. Porceddu, Florian Scotté, Matti Aapro, Satu Salmio, Ana Castro, Vincent Launay-Vacher, Lisa Licitra
Format:	Artigo
Udgivet:	Frontiers Media S.A. 2020-01-01
Fag:	Cisplatin Locally advanced squamous cell carcinoma of the head and neck Toxicity Cetuximab Radiotherapy Chemotherapy
Online adgang:	https://www.frontiersin.org/article/10.3389/fonc.2019.01522/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Vær først til at give en kommentarø!

Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy

Lignende værker